Navigation Links
Research May Yield New Weapons Against Sepsis

The severe blood infection kills more than 33,000 Americans per year, experts say

WEDNESDAY, Feb. 27 (HealthDay News) -- U.S. researchers say they've spotted several potential new drug targets for the serious blood infection known as sepsis.

Sepsis, caused by a bacterial infection that enters the bloodstream, is a severe, difficult-to-treat, and often fatal condition that kills tens of thousands of Americans a year.

In their research in mice, a team at the Scripps Institute in La Jolla, Calif., discovered an important connection between blood coagulation and the immune system.

The study was published in the Feb. 27 online issue of the journal Nature.

"We have identified a key connection of signaling pathways in the cascade of events leading to sepsis. This defines a crucial point where the immune system spirals out of control to cause severe sepsis and where there is an opportunity for therapeutic intervention," research co-leader Wolfram Ruf, a professor in the department of immunology, said in a prepared statement.

In this study, the Scripps team described its discovery of a new cross-talk mechanism involving the vascular coagulation system and certain cells in the immune system. When the researchers disrupted this cross-talk, they saved the lives of mice with sepsis.

These successful proof-of-principle experiments may help improve the diagnosis of various sepsis syndromes and lead to the development of new drugs to treat sepsis, the researchers said.

The Scripps team is now evaluating which targets would be the best candidates for drug therapy and is also looking at this pathway's potential role in other infectious diseases.

Sepsis, one of the leading causes of death among infants and adults in the United States, killed more than 33,000 people in 2004, according to the Centers for Disease Control and Prevention.

A number of therapies, including antibiotics, have been used to treat sepsis over the years, but they have a number of drawbacks.

More information

The Society of Critical Care Medicine has more about sepsis.

-- Robert Preidt

SOURCE: Scripps Research Institute, news release, Feb. 27, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. U of Minn researchers find primary alcohol prevention programs are needed for tweens
2. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
3. Jan Marini Skin Research Introduces Age Intervention(R) Transitions - a New Frontier in Skin Care
4. Efforts to Recruit, Retain and Research Nations Social Workers Gain Bipartisan Support in Congress
5. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
6. AMA Foundation Announces Seed Grant Research Recipients
7. The Low-Fat Diet is Fueling Our Rate of Obesity, Says Researcher Phoenix Gilman
8. NIH awards OHSU researcher $1.2 million to determine causes of, risk factors for pelvic floor injury
9. Researchers identify and shut down protein that fuels ovarian cancer
10. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
11. Penn researchers engineer first system of human nerve-cell tissue
Post Your Comments:
Related Image:
Research May Yield New Weapons Against Sepsis
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology: